Your browser doesn't support javascript.
loading
Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial.
Rosenstock, Julio; Nino, Antonio; Soffer, Joseph; Erskine, Lois; Acusta, Andre; Dole, Jo; Carr, Molly C; Mallory, Jason; Home, Philip.
Afiliação
  • Rosenstock J; Dallas Diabetes Research Center at Medical City, Dallas, TX juliorosenstock@dallasdiabetes.com.
  • Nino A; Research and Development Immuno-Inflammation Therapy Area Unit, GlaxoSmithKline, Collegeville, PA.
  • Soffer J; Research and Development Future Pipelines Discovery, GlaxoSmithKline, Collegeville, PA.
  • Erskine L; Clinical Development, GlaxoSmithKline, King of Prussia, PA.
  • Acusta A; Clinical Statistics, GlaxoSmithKline, Collegeville, PA.
  • Dole J; Research and Development Future Pipelines Discovery, GlaxoSmithKline, Collegeville, PA.
  • Carr MC; Research and Development Future Pipelines Discovery, GlaxoSmithKline, Collegeville, PA.
  • Mallory J; Clinical Development, GlaxoSmithKline, King of Prussia, PA.
  • Home P; Newcastle University, Newcastle upon Tyne, U.K.
Diabetes Care ; 43(10): 2509-2518, 2020 10.
Article em En | MEDLINE | ID: mdl-32694215

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Peptídeo 1 Semelhante ao Glucagon / Controle Glicêmico / Insulina Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetes Care Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Peptídeo 1 Semelhante ao Glucagon / Controle Glicêmico / Insulina Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetes Care Ano de publicação: 2020 Tipo de documento: Article